-
2 months ago | 
stocktitan.net | Jeffrey C. Byrne
AbbVie's FY2024 results reveal a compelling growth story amid the challenging Humira patent cliff transition.
-
2 months ago | 
morningstar.com | Jeffrey C. Byrne
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial ResultsPR NewswireNORTH CHICAGO, Ill., Jan.
-
2 months ago | 
quantisnow.com | Jeffrey C. Byrne
Reports Full-Year Diluted EPS of $2.39 on a GAAP Basis, a Decrease of 12.1 Percent; Adjusted Diluted EPS of $10.12, a Decrease of 8.9 Percent; These Results Include an Unfavorable Impact of $1.52 Per Share Related to 2024 Acquired IPR&D and Milestones Expense Delivers Full-Year Net Revenues of $56.334 Billion, an Increase of 3.7 Percent on a Reported Basis and 4.6 Percent on an Operational Basis Full-Year Global Net Revenues from the Immunology Portfolio Were $26.682 Billion, an Increase of...
-
Dec 8, 2024 | 
arxiv.org | Jeffrey C. Byrne
-
Sep 17, 2024 | 
thegenerositycommission.org | Jeffrey C. Byrne
Long a source of stability, vibrancy, and citizen agency, civil society is American democracy’s singular asset. The organizations, associations, and networks it comprises offer forums for solving shared problems, stewarding community resources, and mobilizing bucket brigades. At its heart are engaged individuals, “everyday” volunteers, givers, and civic leaders who are active in community life, aware of local needs, and attuned to community solutions.
-
Jul 25, 2024 | 
investors.abbvie.com | Jeffrey C. Byrne
0001551152false0001551152 2024-07-252024-07-25 0001551152exch:XCHIus-gaap:CommonStockMember 2024-07-252024-07-25 0001551152us-gaap:CommonStockMemberexch:XNYS 2024-07-252024-07-25 0001551152exch:XNYSabbv:Sec0.750SeniorNotesDue2027Member 2024-07-252024-07-25 0001551152exch:XNYSabbv:Sec2.125SeniorNotesdue2028Member 2024-07-252024-07-25 0001551152abbv:Sec2625SeniorNotesDue2028Memberexch:XNYS 2024-07-252024-07-25 0001551152abbv:Sec2125SeniorNotesDue2029Memberexch:XNYS 2024-07-252024-07-25...
-
Feb 13, 2024 | 
emorybusiness.com | Emory Business |Jeffrey C. Byrne
The faculty of Goizueta Business School have continued to rake in major accomplishments throughout the past year, from publishing new books to receiving recognition for excellence in teaching and research and devoting their time to serve on various board for community service organizations.
-
Feb 13, 2024 | 
brnw.ch | Emory Business |Jeffrey C. Byrne |Goizueta Effect
From Barbie to Dove and Dasani to Sephora, brands are constantly shifting to reflect their markets and make their customers feel seen. Emory University's Goizueta Business School Professor Omar Rodríguez-Vilá joins to discuss the power of brand inclusivity, how to serve the needs of historically underrecognized communities, and what sets inclusive brands apart.
-
Dec 26, 2023 | 
theunion.com | Jeffrey C. Byrne
December 4 Sawaya and Vokom: Ester Sue Sawaya and Kyle Mitchell Vokom McMillan and Lahue: Ingrid Aaron McMillan and Chad David Lahue Largen and Gunnels: Shanel Leearl Largen and Dillon Matthew Gunnels Braniski and McVicker: Toni Lee Rose Braniski and John Andrew McVicker Buksh and Flowers: Fazia Farzana Buksh and Timothy Lawton Flowers Costanza and Rose: Gayle Anne Costanza and Lester Kent Rose December 5 Hartley and Clark: Diana Marie Hartley and Donald Fredrick Clark Junior December 8...
-
Jun 8, 2023 | 
jamanetwork.com | Jeffrey C. Byrne |Barry I Graubard |Eric J. Feuer |Steven Woloshin
Key PointsQuestion Do estimates of mortality due to various causes or all causes combined change when accounting for smoking status in addition to age, sex, and race? Findings This cohort study used the National Cancer Institute’s Know Your Chances website to show that the chance of death due to major causes like heart disease, lung cancer, and all causes combined varies by smoking status.
